Jobaaj Stories- 14 May 2025
Cipla Q4: Soaring Profits, Dim Outlook? Experts Divided – Should You Buy or Sell?
Cipla's Q4 Report: Strong Profits, Cautious OutlookCipla, a major Indian pharmaceutical company, ann
- Jobaaj Stories
- 14 May 2025
Cipla Q4 Profit Up 30%, But Caution Hits Stock—Should Investors Hold, Buy or Exit?
Despite reporting a robust 30% YoY rise in net profit for Q4FY25, pharma giant Cipla saw its shares
- Jobaaj Stories
- 12 May 2025
‘This City Is Ours’ Renewed for Season 2: BBC’s Gritty Crime Drama Strikes Again
In a powerful comeback that thrilled crime drama lovers, This City Is Ours—BBC’s raw, gr
- Jobaaj Stories
- 06 Sep 2022
Cipla, Torrent Pharma & JB Chemicals in the final round to acquire Medley Pharma
Reports suggest that Cipla, JB Chemicals, and Torrent Pharmaceuticals are the participants in the fi
Explore Topics
Newsletter
Tag Clouds